Rate of methadone use among Aboriginal opioid injection drug users

CMAJ. Canadian Medical Association Journal

Volumn 177, Issue 1, 2007, Pages 37-40

  Wood, Evan ^a,b   Montaner, Julio S ^a,b   Li, Kathy ^a   Barney, Lucy ^c   Tyndall, Mark W ^a   Kerr, Thomas ^a,b  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE; METHADONE; METHAMPHETAMINE; OPIATE;

ABORIGINE; ARTICLE; CONTROLLED STUDY; DRUG USE; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION;

EID: 34447272483     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.070105     Document Type: Article

References (15)

1. Strathdee SA, Galai N, Safaeian M, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med 2001;161:1281-8.
2. Wood E, Li K, Small W, et al. Recent incarceration independently associated with syringe sharing by injection drug users. Public Health Rep 2005;120:150-6.
3. Romero-Daza N, Weeks M, Singer M. "Nobody gives a damn if I live or die": violence, drugs, and street-level prostitution in inner-city Hartford, Connecticut. Med Anthropol 2003;22:233-59.
4. Faggiano F, Vigna-Taglianti F, Versino E, et al. Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst Rev 2003;3:CD002208.
5. Mattick RP, Breen C, Kimber J, et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2003;2:CD002209.
6. Amato L, Minozzi S, Davoli M, et al. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev 2004;4:CD004147.
7. Wood E, Tyndall MW, Montaner JS, et al. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ 2006;175:1399-404.
8. Craib KJ, Spittal PM, Wood E, et al. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ 2003;168:19-24.
9. Wood E, Kerr T, Palepu A, et al. Slower uptake of HIV antiretroviral therapy among Aboriginal injection drug users. J Infect 2006;52:233-6.
10. Benoit C, Carroll D, Chaudhry M. In search of a healing place: Aboriginal women in Vancouver's Downtown Eastside. Soc Sci Med 2003;56:821-33.
11. Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997;11:F59-65.
12. Des Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet 1999;353:1657-61.
13. Wardman D, Clement K, Quantz D. Access and utilization of health services by British Columbia's rural Aboriginal population. Int J Health Care Qual Assur Inc Leadersh Health Serv 2005;18:xxvi-xxxi.
14. Shah BR, Gunraj N, Hux JE. Markers of access to and quality of primary care for aboriginal people in Ontario, Canada. Am J Public Health 2003;93:798-802.
15. Reading J. The quest to improve Aboriginal health [editorial]. CMAJ 2006;174:1233.